LGM Pharma
About LGM Pharma
LGM Pharma is an innovation-driven API company, involved in distribution of quality cGMP pharma ingredients to leading pharmaceutical companies. LGM specializes in providing integrated sourcing options, complete technical capabilities and regulatory documentation support for a wide range of APIs.
LEADERSHIP:
COO: Mendy Schurder
FOLLOW LGM PHARMA:
Tweets by LGM Pharma
7 articles about LGM Pharma
-
LGM Pharma Unveils Enhanced Analytical Testing Services and Expands CDMO Portfolio with Additional Suppository Manufacturing Capabilities
3/13/2024
LGM Pharma announced a significant enhancement of its capabilities: a 50% expansion and an investment exceeding $2 million in its standalone offering for Analytical Testing Services alongside the introduction of new suppository manufacturing capabilities to its contract development and manufacturing portfolio.
-
LGM Pharma Reports Strong Revenues in First Year of CDMO Operations Along With Continued Growth in Its API Sourcing Business
3/15/2023
LGM Pharma today reported strong growth in 2022 in both its long-established Active Pharmaceutical Ingredient (API) division and its new contract development and manufacturing (CDMO) division.
-
LGM Pharma’s Unique Mix of API Sourcing and CDMO Services Is Fueling Robust Growth
5/17/2022
LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, reported that its unique mix of active pharmaceutical ingredient sourcing and contract development and manufacturing services is helping to drive robust growth.
-
LGM Pharma Launches Standalone Analytical Services for Drug Developers and Manufacturers
7/8/2021
LGM Pharma today announced the launch of its new Analytical Services offering that provides analytical testing and stability services to pharmaceutical developers and manufacturers, including compounding pharmacies.
-
LGM Pharma Expands Client Service Offerings Supporting the Provision of High Quality Active Pharmaceutical Ingredients (APIs) For 503B Outsourcing Facilities
6/24/2019
Offering an expanded set of value-added services to support its clients who supply APIs to compounding pharmacies under section 503B of the 2013 Federal Food, Drug, and Cosmetic Act
-
Generational Equity Advises LGM Pharma in its Sale to New Harbor Capital
12/6/2017
Generational Equity is pleased to announce a majority acquisition of its client, LGM Pharma, by New Harbor Capital LLC.
-
LGM Pharma Announces Appointment Of New Senior Vice President Of Business Development
7/28/2017